Roivant Sciences Ltd. · NASDAQ:ROIV

Gline Matthew reported 7 trades in Roivant Sciences Ltd. shares (Form 4)

Traded Nov 10 to Nov 12, 2026 · Filed Nov 12, 2026

From Nov 10 to Nov 12, 2026, Gline Matthew (Director, CEO) reported 7 trades in Roivant Sciences Ltd. shares at an average US$41.01 for US$6.41M, leaving 16,391,229 shares. Filed Nov 12, 2026 (Form 4).

Shares
156,307 shares
Price
US$41.01 average (US$40.36 to US$42.01)
Value
US$6.41M
Holding after
16,391,229 shares
Trading plan
No
Role
Director, CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 10, 2026Common SharesOther25,841US$40.4316,523,295Direct
Nov 10, 2026Common SharesOther32,490US$41.1316,490,805Direct
Nov 11, 2026Common SharesOther30,083US$41.6316,460,722Direct
Nov 11, 2026Common SharesOther18,905US$42.0116,441,817Direct
Nov 12, 2026Common SharesOther41,179US$40.3616,400,638Direct
Nov 12, 2026Common SharesOther7,809US$41.1316,392,829Direct
Nov 12, 2026Common SharesShares withheld for tax1,600US$41.8516,391,229Direct

Source

Download original · View original at SEC

Related